|
CN105272960A
|
|
Preparation method of canagliflozin intermediate 2-(2-methyl-5-bromobenzyl)-5-(4-fluorobenzene)thiophene
|
|
CN105085490A
|
|
New sunitinib malate crystal form and preparation method therefor
|
|
CN105085475A
|
|
Method for synthesizing alogliptin intermediate
|
|
CN104693090A
|
|
Silodosin and preparation methods for intermediates thereof
|
|
CN104557898A
|
|
Azilsartan tetrahydrofuran solvate and preparation method thereof
|
|
CN104513221A
|
|
Preparation method of ticagrelor intermediate with optical activity
|
|
CN104370800A
|
|
Saxagliptin salt and preparation method thereof
|
|
CN104370934A
|
|
Prasugrel salt and preparation method thereof
|
|
CN104341410A
|
|
New Dasatinib crystal form and preparation method thereof
|
|
CN104341315A
|
|
Preparation method of agomelatine crystal form I
|
|
CN104341336A
|
|
Novel method for synthesizing apixaban important intermediate
|
|
CN104140425A
|
|
Method of preparing antiplatelet aggregation medicine ticagrelor
|
|
CN104098517A
|
|
Lapatinib intermediate preparation method
|
|
CN104098525A
|
|
Preparation method for 4-(4-aminophenyl)morpholine-3-one
|
|
CN103965059A
|
|
Method for preparation of (1R,2S)-2-(3,4-difluorophenyl)cyclopropylamine
|
|
CN103965196A
|
|
Method for preparing antiplatelet aggregation drug ticagrelor
|
|
CN103910690A
|
|
New iressa crystal form and preparation methods thereof
|
|
CN103896922A
|
|
Novel sunitinib salts and preparing method thereof
|
|
CN103896943A
|
|
Varenicline salt and preparing method thereof
|
|
CN103896925A
|
|
A lapatinib salt and a preparing method thereof
|
